OCS Stock Analysis: Buy, Sell, or Hold?
OCS - Oculis Holding AG Ordinary shares
$26.63
-0.40 (-1.48%)
▼
5d:
+6.56%
30d:
-3.93%
90d:
+33.35%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When OCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OCS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: OCS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: OCS is currently trading at $26.63, which is considered fair relative to its 30-day fair value range of $25.12 to $28.32.
Technical Outlook: Technically, OCS is in a strong uptrend. Immediate support is located at $24.02, while resistance sits at $27.93.
Market Sentiment: OCS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.93 (+76.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OCS is in a strong uptrend. Immediate support is located at $24.02, while resistance sits at $27.93.
Market Sentiment: OCS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.93 (+76.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$25.12 -
$28.32
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 76.2% below Wall St target ($46.93)
Fair Price Analysis
30-Day Fair Range
$25.12 -
$28.32
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$24.02
Resistance Level
$27.93
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.80
Wall Street Target
$46.93
(+76.2%)
Revenue Growth (YoY)
13600.0%
Share & Embed Analysis
Last updated: April 05, 2026 5:02 PM ET
Data refreshes hourly during market hours. Next update: 6:02 PM
Data refreshes hourly during market hours. Next update: 6:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCS showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 60 HOLD |
